or Try an Advanced Search...

    Lupus Nephritis Stocks List

    Symbol Grade Name % Change
    KYTX F Kyverna Therapeutics, Inc. 1.11
    BIIB D Biogen Idec Inc. 0.23
    AUPH D Aurinia Pharmaceuticals Inc -0.17
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Lupus Autoimmune Disease Biopharmaceutical Immunosuppressants Medicine Multiple Sclerosis Nephritis Alzheimer's Disease Autoimmune Disorders Autoimmunity Biotechnology Cd20 Chronic Lymphocytic Leukemia Clinical Development Clinical Trial Product Clinical Trial Products Degenerative Disease Disability Drugs Hemophilia

    Related ETFs - A few ETFs which own one or more of the above listed Lupus Nephritis stocks.

    Symbol Grade Name Weight
    BIS F ProShares UltraShort Nasdaq Biotechnology 6.12
    IBRN D iShares Neuroscience and Healthcare ETF 5.17
    PBE C PowerShares Dynamic Biotech & Genome 5.07
    BBH B Market Vectors Biotech ETF 4.58
    MNTL C Tema Neuroscience and Mental Health ETF 4.26
    View all Lupus Nephritis ETFs...
    Compare ETFs
    Compare BBH to MNTL Compare IBRN to BBH Compare PBE to MNTL

        Lupus Nephritis Stocks Recent News

        Date Stock Title
        May 17 BIIB Ionis, Biogen Down on Ending Development of ALS Drug
        May 16 BIIB Biogen also drops collaboration with Ionis on Angelman syndrome candidate
        May 16 BIIB Biogen and Ionis drop ALS candidate after trial setback
        May 16 BIIB Biogen, Ionis shelve ALS drug following study failure
        May 16 BIIB REFILE-UPDATE 2-Biogen, Ionis to discontinue development of experimental ALS drug
        May 16 BIIB Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
        May 16 BIIB Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
        May 15 BIIB Eisai projects major growth for Alzheimer's therapy Leqembi
        May 15 BIIB Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
        May 15 BIIB Biogen Stock Continues Its 20% Sprint On A Twist In Alzheimer's Treatment
        May 15 KYTX Kyverna Therapeutics reports Q1 GAAP EPS of -$1.12
        May 15 BIIB Eisai sets new revenue target for Alzheimer’s drug Leqembi
        May 15 BIIB Biogen partner Eisai begins FDA submissions for injectable Alzheimer’s therapy
        May 15 BIIB UPDATE 1-Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
        May 14 BIIB Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status
        May 14 BIIB Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
        May 14 KYTX Kyverna Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
        May 14 AUPH Analysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation’s Spring Clinical Meeting 2024
        May 13 BIIB 15 Most Depressed States in the US
        May 11 BIIB 3 S&P 500 Stocks to Rival Nvidia’s 2023 Performance in the Second Half of 2024
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Lupus Autoimmune Disease Biopharmaceutical Immunosuppressants Medicine Multiple Sclerosis Nephritis Alzheimer's Disease Autoimmune Disorders Autoimmunity Biotechnology Cd20 Chronic Lymphocytic Leukemia Clinical Development Clinical Trial Product Clinical Trial Products Degenerative Disease Disability Drugs Hemophilia
        Lupus Nephritis

        Lupus nephritis (also known as SLE nephritis) is an inflammation of the kidneys caused by systemic lupus erythematosus (SLE), an autoimmune disease. It is a type of glomerulonephritis in which the glomeruli become inflamed. As the result of SLE, the cause of glomerulonephritis is said to be secondary and has a different pattern and outcome from conditions with a primary cause originating in the kidney.

        More about Lupus Nephritis
        Browse All Tags